Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Condition: Non-small Cell Carcinoma Interventions: Drug: Binimetinib; Drug: Pembrolizumab Sponsor: University Health Network, Toronto Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Lung Cancer | Non-Small Cell Lung Cancer | Research | Study